Kathmere Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1M | Sell |
3,979
-270
| -6% | -$210K | 0.24% | 75 |
|
|
2025
Q1 | $3.51M | Buy |
4,249
+101
| +2% | +$83.4K | 0.3% | 59 |
|
|
2024
Q4 | $3.2M | Buy |
4,148
+229
| +6% | +$177K | 0.29% | 62 |
|
|
2024
Q3 | $3.47M | Sell |
3,919
-67
| -2% | -$59.4K | 0.33% | 53 |
|
|
2024
Q2 | $3.61M | Sell |
3,986
-661
| -14% | -$598K | 0.38% | 47 |
|
|
2024
Q1 | $3.62M | Sell |
4,647
-224
| -5% | -$174K | 0.41% | 44 |
|
|
2023
Q4 | $2.84M | Buy |
4,871
+2
| +0% | +$1.17K | 0.37% | 47 |
|
|
2023
Q3 | $2.62M | Buy |
4,869
+746
| +18% | +$401K | 0.39% | 49 |
|
|
2023
Q2 | $1.93M | Buy |
4,123
+45
| +1% | +$21.1K | 0.3% | 53 |
|
|
2023
Q1 | $1.4M | Sell |
4,078
-508
| -11% | -$174K | 0.23% | 56 |
|
|
2022
Q4 | $1.68M | Buy |
4,586
+1,073
| +31% | +$393K | 0.3% | 53 |
|
|
2022
Q3 | $1.14M | Buy |
3,513
+822
| +31% | +$266K | 0.23% | 58 |
|
|
2022
Q2 | $873K | Buy |
2,691
+1,299
| +93% | +$421K | 0.16% | 58 |
|
|
2022
Q1 | $399K | Buy |
+1,392
| New | +$399K | 0.07% | 98 |
|